MoPNG Gas Priority 2026: Pharma Stocks Face ₹6,700 Cr Revenue Risk

Priority Allocation Creates Winners and Losers The Ministry of Petroleum and Natural Gas's Supply Regulation Order 2026 introduces a four-tier priority system that fundamentally reshapes natural gas allocation across industrial sectors. For pharmaceutical investors, this represents a ₹6,700 crore revenue-at-risk scenario across major listed companies, with fertilizer manufacturers gaining at the expense of drug producers. Under the new framework, fertilizer production secures Tier-1 priority alongside power generation, while pharmaceutical manufacturing drops to Tier-3, competing with petrochemicals and other industrial applications. This structural shift in gas access could compress margins for India's largest pharma exporters, particularly those dependent on gas-intensive API manufacturing. Sun Pharma (SUNPHARMA), India's largest pharmaceutical company by market cap at ₹4.17 lakh crore, faces moderate risk with ₹2,328 crore in revenue exposure. Trading at a PE of 34.34x with quarterly revenues of ₹15,520 crore, the company's 14.07% ROE and strong ROCE of 20.21% provide some cushion against input cost pressures. However, the stock's FairStock score of 55 reflects these emerging headwinds. The allocation hierarchy creates immediate cost implications. Dr Reddy's Labs (DRREDDY) carries ₹1,313 crore in at-risk revenue, while Aurobindo Pharma (AUROPHARMA) faces ₹1,297 crore exposure. Both companies score 45-48 on FairStock's risk assessment, indicating moderate vulnerability to gas supply disruptions. Chemical Feedstock Dependency Amplifies Risk The regulatory change hits hardest where pharmaceutical manufacturing intersects with gas-dependent chemical feedstocks. Ammonia, critical for several API synthesis pathways, faces critical risk as a direct gas feedstock. India produces 72% of its ammonia domestically, but this production depends heavily on natural gas availability at competitive prices. Propylene, another critical pharmaceutical intermediate, shows 70% d...